Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Grape King Bio's share price for the quarter that ended in Dec. 2024 was NT$149.5. Grape King Bio's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 148 Mil. Therefore, Grape King Bio's market cap for the quarter that ended in Dec. 2024 was NT$22,146 Mil.
Grape King Bio's quarterly market cap
declined
from Jun. 2024 (NT$22,739 Mil) to Sep. 2024 (NT$21,258 Mil) but then
increased
from Sep. 2024 (NT$21,258 Mil) to Dec. 2024 (NT$22,146 Mil).
Grape King Bio's annual market cap
declined
from Dec. 2022 (NT$24,887 Mil) to Dec. 2023 (NT$23,109 Mil) and
declined
from Dec. 2023 (NT$23,109 Mil) to Dec. 2024 (NT$22,146 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Grape King Bio's Enterprise Value for Today is NT$16,944 Mil.
Grape King Bio Market Cap Historical Data
The historical data trend for Grape King Bio's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Grape King Bio's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grape King Bio's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Market Cap distribution charts can be found below:
* The bar in red indicates where Grape King Bio's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Grape King Bio's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grape King Bio (TPE:1707) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Grape King Bio Market Cap Related Terms
Thank you for viewing the detailed overview of Grape King Bio's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TPE:1707 has been successfully added to your 